UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 810

Sortiert nach

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporosis international, 2019-01, Vol.30 (1), p.3-44

2019

Volltextzugriff (PDF)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporosis international, 2013-01, Vol.24 (1), p.23-57

2013

Volltextzugriff (PDF)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Osteoporosis international, 2008-04, Vol.19 (4), p.399-428

2008

Volltextzugriff (PDF)

Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Calcified tissue international, 2019-03, Vol.104 (3), p.235-238

2019

Volltextzugriff (PDF)

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

Bone (New York, N.Y.), 2015-09, Vol.78, p.216-224

2015

Volltextzugriff (PDF)

Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures

Osteoporosis international, 2017-05, Vol.28 (5), p.1507-1529

2017

Volltextzugriff (PDF)

Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

Osteoporosis international, 2018-09, Vol.29 (9), p.1933-1948

2018

Volltextzugriff (PDF)

Diabetes is a risk factor for knee osteoarthritis progression

Osteoarthritis and cartilage, 2015-06, Vol.23 (6), p.851-859

2015

Volltextzugriff (PDF)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Current medical research and opinion, 2013-04, Vol.29 (4), p.305-313

2013

Volltextzugriff (PDF)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

Osteoporosis international, 2020-01, Vol.31 (1), p.1-12

2020

Volltextzugriff (PDF)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

Osteoporosis international, 2017-07, Vol.28 (7), p.2023-2034

2017

Volltextzugriff (PDF)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates

The journal of clinical endocrinology and metabolism, 2016-08, Vol.101 (8), p.3163-3170

2016

Volltextzugriff (PDF)

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Osteoporosis international, 2020-12, Vol.31 (12), p.2271-2286

2020

Volltextzugriff (PDF)

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France

Osteoporosis international, 2019-03, Vol.30 (3), p.649-658

2019

Volltextzugriff (PDF)

Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review

Osteoporosis international, 2020-09, Vol.31 (9), p.1645-1669

2020

Volltextzugriff (PDF)

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

Osteoporosis international, 2021-04, Vol.32 (4), p.611-617

2021

Volltextzugriff (PDF)

Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

Osteoporosis international, 2008-06, Vol.19 (6), p.811-818

2008

Volltextzugriff (PDF)

The prevalence and burden of arthritis

Rheumatology (Oxford, England), 2002-04, Vol.41 (S1), p.3-6

REGINSTER, J.-Y

2002

Volltextzugriff (PDF)

Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Aging clinical and experimental research, 2019-01, Vol.31 (1), p.15-17

2019

Volltextzugriff (PDF)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

Osteoporosis international, 2011-02, Vol.22 (2), p.373-390

2011

Volltextzugriff (PDF)

Frailty and sarcopenia: definitions and outcome parameters

Osteoporosis international, 2012-07, Vol.23 (7), p.1839-1848

2012

Volltextzugriff (PDF)

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

Osteoporosis international, 2017-03, Vol.28 (3), p.767-774

2017

Volltextzugriff (PDF)

Bone health assessment in older people with or without muscle health impairment

Osteoporosis international, 2018-05, Vol.29 (5), p.1057-1067

2018

Volltextzugriff (PDF)

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

Osteoporosis international, 2021-03, Vol.32 (3), p.595-606

2021

Volltextzugriff (PDF)

Phosphate wasting disorders in adults

Osteoporosis international, 2018-11, Vol.29 (11), p.2369-2387

2018

Volltextzugriff (PDF)

1 – 25 von 810

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(764)
Mit Volltextzugriff
(651)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice

Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures

Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

Diabetes is a risk factor for knee osteoarthritis progression

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France

Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

The prevalence and burden of arthritis

Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

Frailty and sarcopenia: definitions and outcome parameters

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates

Bone health assessment in older people with or without muscle health impairment

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

Phosphate wasting disorders in adults

Suchergebnisse filtern